Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults
Wei Xia, Jianbo Shao, Yu Guo, Xuehua Peng, Zhen Li, Daoyu Hu, Wei Xia, Jianbo Shao, Yu Guo, Xuehua Peng, Zhen Li, Daoyu Hu
Abstract
Purpose: To discuss the different characteristics of clinical, laboratory, and chest computed tomography (CT) in pediatric patients from adults with 2019 novel coronavirus (COVID-19) infection.
Methods: The clinical, laboratory, and chest CT features of 20 pediatric inpatients with COVID-19 infection confirmed by pharyngeal swab COVID-19 nucleic acid test were retrospectively analyzed during 23 January and 8 February 2020. The clinical and laboratory information was obtained from inpatient records. All the patients were undergone chest CT in our hospital.
Results: Thirteen pediatric patients (13/20, 65%) had an identified history of close contact with COVID-19 diagnosed family members. Fever (12/20, 60%) and cough (13/20, 65%) were the most common symptoms. For laboratory findings, procalcitonin elevation (16/20, 80%) should be pay attention to, which is not common in adults. Coinfection (8/20, 40%) is common in pediatric patients. A total of 6 patients presented with unilateral pulmonary lesions (6/20, 30%), 10 with bilateral pulmonary lesions (10/20, 50%), and 4 cases showed no abnormality on chest CT (4/20, 20%). Consolidation with surrounding halo sign was observed in 10 patients (10/20, 50%), ground-glass opacities were observed in 12 patients (12/20, 60%), fine mesh shadow was observed in 4 patients (4/20, 20%), and tiny nodules were observed in 3 patients (3/20, 15%).
Conclusion: Procalcitonin elevation and consolidation with surrounding halo signs were common in pediatric patients which were different from adults. It is suggested that underlying coinfection may be more common in pediatrics, and the consolidation with surrounding halo sign which is considered as a typical sign in pediatric patients.
Keywords: COVID-19; child; clinical features; infection; tomography.
Conflict of interest statement
The authors declare that there are no conflict of interests.
© 2020 Wiley Periodicals, Inc.
Figures
References
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497‐506.
- Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727‐733.
- Pullano G, Pinotti F, Valdano E, Boelle P‐Y, Poletto C, Colizza V. Novel coronavirus (2019‐nCoV) early‐stage importation risk to Europe, January 2020. Euro Surveill. 2020;25:2000057.
- General Office of the National Health Commission of China. Diagnosis and Treatment Protocol for 2019‐nCoV. 5th ed. Beijing, China: National Health Commission of China; 2020.
- Parry J. Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019‐nCOV in the city. Brit Med J. 2020;368:m351.
- Riou J, Althaus CL. Pattern of early human‐to‐human transmission of Wuhan 2019 novel coronavirus (2019‐nCoV), December 2019 to January 2020. Euro Surveill. 2020;25:7‐11.
- Hui DS, Azhar EI, Madani TA, et al. The continuing 2019‐nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264‐266.
- Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019‐nCoV pneumonia. Transl Pediatr. 2020;9:51‐60.
- Simon L, Gauvin F, Amre DK, Saint‐Louis P, Lacroix J. Serum procalcitonin and C‐reactive protein levels as markers of bacterial infection: a systematic review and meta‐analysis. Clin Infect Dis. 2004;39:206‐217.
- Kanne JP. Chest CT findings in 2019 novel coronavirus (2019‐nCoV) infections from Wuhan, China: key points for the radiologist. Radiology. 2020.
- Song F, Shi N, Shan F, et al. Emerging coronavirus 2019‐nCoV pneumonia. Radiology. 2020.
- Virkki R, Juven T, Rikalainen H, Svedstrom E, Mertsola J, Ruuskanen O. Differentiation of bacterial and viral pneumonia in children. Thorax. 2002;57:438‐441.
Source: PubMed